Bringing Specificity to Cancer Treatment

Affibody is focused on improving the treatment of each individual cancer patient. To achieve this, the company is developing an exciting pipeline of molecular imaging agents and individualized targeted treatments based on its unique Affibody® molecules.

Affibody® molecules can target specific tumor proteins that play an important role in the diagnosis or treatment of cancer, such as HER2 present in aggressive forms of breast cancer. Affibody® molecules are well suited for molecular imaging and the same Affibody® molecule with a cytotoxic payload can also be used for targeted therapy.
 
View an animation of how the Affibody® technology will enable cancer specialists to locate and treat tumors and metastases!